Emergent BioSolutions Inc. 4

SVP Paul Anthony Williams sold 4,000 shares of Emergent BioSolutions Inc. common stock at a weighted average price of about $8.44 per share under a Rule 10b5-1 plan.

On 2026-04-01, Paul Anthony Williams, SVP, Products Business of Emergent BioSolutions Inc., sold 4,000 shares of the company’s common stock at a weighted average price of approximately $8.44 per share, for proceeds of about $33,760. The sales were executed under a Rule 10b5-1 trading plan adopted on November 14, 2025, and occurred in multiple trades within a price range of $8.34 to $8.54. Following this disposition, Williams beneficially owned 62,681 shares of Emergent BioSolutions common stock, representing an approximate post-transaction holding value of about $515,000 based on the current market price.

Filing Facts

CIK

1367644

Ticker

EBS

Form

4

Source Type

sec

Accession

0001961994-26-000013

Alert Tier

5